Alexion Pharma (Switzerland)
At Alexion, our mission is to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, as well as supportive technologies and healthcare services.
Basic Information
- Category: business
- Website: http://www.alexionpharma.eu/
Documented Facts
- Phone: +41 44 457 40 00 (No linked source recorded for this statement.)
- Email: clinicaltrials@alexion.com (No linked source recorded for this statement.)
Evidence and Sources
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Alexion Pharma (Switzerland).
- Canonical profile: https://brandsource.ai/brands/alexion-pharma-switzerland
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/alexion-pharma-switzerland/json-ld
- Citation profile API: https://brandsource.ai/api/brands/alexion-pharma-switzerland/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (88/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
At Alexion, our mission is to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, as well as supportive technologies and healthcare services.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 supporting sources linked.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.